MetaStat Competitors and Similar CompaniesClear all
MetaStat's competitors and similar companies include Immutep and Bold Therapeutics.
 MetaStat MetaStat, Inc. develops and commercializes diagnostic tests for risk of cancer metastasis, companion diagnostics and anti-metastatic drugs. |  Immutep Immutep (formerly Prima BioMed) is a biotechnology company focused on developing autoimmune and cancer immunotherapy treatment. |  Bold Therapeutics Bold Therapeutics is a biotechnology company developing cancer therapy for the treatment of gastric, pancreatic, colorectal, and other cancers. | |
Founding Date | Founding Date 2010 | Founding Date 2001 | Founding Date 2018 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Boston, US HQ | Locations Sydney, AU HQ Sydney, AU The Rocks, AU Orsay, FR Berlin, DE Leipzig, DE | Locations Vancouver, CA HQ |
Employees | Employees 6 | Employees 2427% decrease | Employees 205% increase |
Valuation ($) | Valuation ($) 20.6 k | Valuation ($) 282.4 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $23.3k (FY, 2018) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($3.2m) (FY, 2018) | Net income ($61.4m) (FY, 2025) | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
Immutep
HQ
Sydney, AU
Employees
24↓ 27% decrease
Immutep (formerly Prima BioMed) is a biotechnology company focused on developing autoimmune and cancer immunotherapy treatment.
View companyBold Therapeutics
HQ
Vancouver, CA
Employees
20↑ 5% increase
Bold Therapeutics is a biotechnology company developing cancer therapy for the treatment of gastric, pancreatic, colorectal, and other cancers.
View company